About Our Hepatitis C Blog

Welcome to the newly launched hepatitis C blog!

The goal of this global hepatitis C blog is to encourage communication and break down communication barriers so clinicians and their supportive care teams can effectively confront the challenges associated with screening, diagnosing, treating, and managing increasing numbers of individuals with hepatitis C. This blog is supported by Elsevier Multimedia Publishing and the American Journal of Medicine (AJM), and serves as a companion to their comprehensive, online, global educational initiative, the AJM Hepatitis C Resource Center (hepcresource.amjmed.com).

The AJM Hepatitis C Resource Center provides both primary care providers and specialists with continually updated treatment guidelines, and an up-to-date repository of informative, freely-available, full-text articles to encourage effective HCV screening and diagnosis, and to highlight the promise of novel treatment regimens.

About The American Journal of Medicine

The “Green Journal” publishes original clinical research of interest to physicians in internal medicine, both in academia and community-based practice. The American Journal of Medicine is the official journal of the Alliance for Academic Internal Medicine, a prestigious group comprised of chairs of departments of internal medicine at more than 125 medical schools across the country. Each issue carries useful reviews as well as seminal articles of immediate interest to the practicing physician, including peer-reviewed, original scientific studies that have direct clinical significance, and position papers on health care issues, medical education, and public policy. The journal’s ISI factor – the international measure of cited manuscripts and scientific impact – is fourteenth in the world among all general medical journals.  The Editor-in-Chief is Joseph Alpert, MD.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey—and publishes over 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).